Benefits of ERCPs outweigh superbug risks, FDA says

Modern Healthcare (complimentary online subscription): The U.S. Food and Drug Administration Wednesday advised health providers not to cancel surgical procedures involving the use of the medical endoscopes. Endoscopes have been linked to drug-resistant superbug outbreaks at two California hospitals in recent months, but the FDA said the benefits of performing such procedures still outweigh the potential risks.

Read article